相似文献
1
Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.
Bull World Health Organ. 1979;57(2):275-9.
2
A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
Bull World Health Organ. 1985;63(2):339-43.
3
4
A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Bull World Health Organ. 1987;65(3):369-73.
5
A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
Bull World Health Organ. 1987;65(3):357-61.
6
An open, randomized, phase III clinical trial of mefloquine and of quinine plus sulfadoxine-pyrimethamine in the treatment of symptomatic falciparum malaria in Brazil.
Bull World Health Organ. 1985;63(3):603-9.
7
Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Bull World Health Organ. 1987;65(3):363-7.
8
Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Trans R Soc Trop Med Hyg. 1988;82(4):538-40. doi: 10.1016/0035-9203(88)90496-8.
9
The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Southeast Asian J Trop Med Public Health. 1987 Jun;18(2):223-5.
10
Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine.
Lancet. 1986 Feb 15;1(8477):377. doi: 10.1016/s0140-6736(86)92334-2.
引用本文的文献
1
Identification of amitriptyline HCl, flavin adenine dinucleotide, azacitidine and calcitriol as repurposing drugs for influenza A H5N1 virus-induced lung injury.
PLoS Pathog. 2020 Mar 16;16(3):e1008341. doi: 10.1371/journal.ppat.1008341. eCollection 2020 Mar.
2
Tracking origins and spread of sulfadoxine-resistant Plasmodium falciparum dhps alleles in Thailand.
Antimicrob Agents Chemother. 2011 Jan;55(1):155-64. doi: 10.1128/AAC.00691-10. Epub 2010 Oct 18.
3
Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients.
Bull World Health Organ. 1995;73(5):631-42.
4
High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand.
Bull World Health Organ. 1993;71(3-4):377-83.
5
Falciparum malaria in eastern Thailand: a randomized trial of the efficacy of a single dose of mefloquine.
Bull World Health Organ. 1994;72(1):73-8.
6
Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
Drugs. 1993 Mar;45(3):430-75. doi: 10.2165/00003495-199345030-00009.
7
Decrease in susceptibility of Plasmodium falciparum to mefloquine in continuous culture.
Bull World Health Organ. 1981;59(2):249-52.
8
An evaluation of five regimens for the outpatient therapy of falciparum malaria in Thailand 1980-81.
Bull World Health Organ. 1982;60(6):907-12.
9
Current concepts in the treatment of malaria in children.
Indian J Pediatr. 1984 Sep-Oct;51(412):579-85. doi: 10.1007/BF02776627.
10
A new in vitro test for pyrimethamine/sulfadoxine susceptibility of Plasmodium falciparum and its correlation with in vivo resistance in Kenya.
Bull World Health Organ. 1984;62(4):615-21.
本文引用的文献
1
Treatment of falciparum malaria from Vietnam with a phenanthrene methanol (WR 33063) and a quinoline methanol (WR 30090).
Antimicrob Agents Chemother. 1973 Feb;3(2):224-7. doi: 10.1128/AAC.3.2.224.
2
A review of the drug sensitivity of Plasmodium falciparum in Thailand.
Southeast Asian J Trop Med Public Health. 1972 Jun;3(2):190-7.
3
Mefloquine (WR 142,490) in the treatment of human malaria.
Science. 1975 Nov 21;190(4216):792-4. doi: 10.1126/science.1105787.
Zotero 插件